Fluid drainage devices, systems and methods

The collapsible drainage device with a deformable body and reinforcing element addresses the flexibility issues of conventional devices, reducing tissue irritation and scarring to effectively manage glaucoma by stabilizing intraocular pressure.

JP2025502262AActive Publication Date: 2025-01-24WL GORE & ASSOC INC
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
JP2024541985
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2022-01-12
Filing Date
2023-01-12
Publication Date
2025-01-24
Estimated Expiration
2043-01-12

AI Technical Summary

Technical Problem

Conventional glaucoma drainage devices are bulky and lack flexibility, leading to relative movement between the device and surrounding tissue, causing irritation, chronic inflammatory reactions, and scarring, which prevents proper functioning and increases intraocular pressure.

Method used

A collapsible drainage device with a collapsible body portion that can deform into a non-planar state during implantation, featuring a temporary reinforcing element to maintain a planar configuration during insertion, and a microporous material to facilitate tissue adhesion and reduce scarring.

Benefits of technology

The device minimizes tissue irritation and scarring, ensuring proper fluid drainage and absorption, thereby stabilizing intraocular pressure and preventing glaucoma progression.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2025502262000001_ABST
    Figure 2025502262000001_ABST
Patent Text Reader

Abstract

Disclosed is a drainage device for draining bodily fluid from an eye to tissue external to the eye, as well as methods of forming the drainage device and using the drainage device to treat glaucoma. The drainage device is at least partially implantable within the tissue of the eye and includes a collapsible body portion defining a reservoir and a conduit having a first end fluidly coupled to the reservoir and a second end insertable into the eye to facilitate drainage of bodily fluid into the conduit. When collapsed, the body portion includes a first planar state that transforms to a second non-planar state, which can be a folded, deformed, bent, or wrinkled state.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS This application claims the benefit of U.S. Provisional Application No. 63 / 298,854, filed January 12, 2022, the contents of which are incorporated by reference herein in their entirety for all purposes.

[0002] Field The present disclosure relates generally to devices, systems and methods for draining bodily fluids and diverting the fluid to be reabsorbed elsewhere in the body, and more particularly, to devices, systems and methods for draining aqueous humor from the anterior chamber of a patient's eye so that it can be reabsorbed into the body. [Background technology]

[0003] background Various medical interventions involve draining excess fluid from one part of the body and redirecting it to another part of the body where it can be reabsorbed. In certain instances, this drainage is accomplished by minimally invasive surgery, such as endoscopic third ventriculostomy (ETV) and choroid plexus ablation (CPC). In other instances, this drainage is accomplished post-operatively by implantable medical devices, such as shunts. Various forms of shunts have proven useful in a variety of medical procedures and are used to treat many diseases, such as hydrocephalus and glaucoma.

[0004] If untreated, excess fluid can cause an unhealthy buildup of pressure. For example, glaucoma is a progressive eye disease characterized by an increase in intraocular pressure. Aqueous humor is the fluid that fills the anterior chamber of the eye and contributes to intraocular or intraocular fluid pressure. This increase in intraocular pressure is usually caused by an insufficient amount of aqueous humor being absorbed into the body. In some instances, aqueous humor is not absorbed fast enough or even at all, while in other instances, aqueous humor is additionally or alternatively produced too quickly. Increased intraocular pressure is accompanied by a gradual, sometimes permanent, loss of vision in the affected eye.

[0005] Many attempts have been made to treat glaucoma. However, some conventional devices are relatively bulky and lack the flexibility, compliance and device / tissue adhesion required to avoid relative movement between the device and the surrounding tissue. Such movement can result in continuous irritation to the surrounding tissue and cause irritation at the implant procedure site. In turn, the irritation can lead to increased chronic inflammatory tissue reaction, excessive scarring at the device site, and increased risk of device erosion due to conjunctivitis and endophthalmitis. The scar tissue effectively prevents reabsorption of aqueous humor without erosion. These complications can prevent the device from functioning properly. This results in a gradual increase in intraocular pressure and progression of glaucoma.

[0006] 1A and 1B show a glaucoma drainage device 100 as known in the art. The device 100 includes a plate body 102 that defines a surface through which the drained fluid (aqueous humor) flows, and a drainage tube 104 that allows the fluid (aqueous humor) to flow over the surface of the plate body. The plate body 102 has a maximum thickness "t1", which in the illustrated example is 2.1 mm, and is made from medical grade silicone that lacks the flexibility to conform to the curvature of the eye during the implantation procedure. Thus, the plate body 102 has a preformed (i.e., prior to implantation) curvature (defined by dashed line CC in FIG. 1B) that approximates the curvature of the surface of the eye. The curvature CC is fixed and is the same for all glaucoma drainage devices, and therefore in some cases cannot accommodate the unique curvature of each patient's eye.

[0007] See Figures 1C-1H for an exemplary procedure for implanting the glaucoma drainage device 100 into the ocular tissue of a patient. In Figure 1C, a fornix-based incision 17 is made in the conjunctiva 13 of the patient's eye 10 using a scalpel. In Figure 1D, the plate body 102 of the glaucoma drainage device 100 is inserted into the tissue pocket made by the incision 17, with the entire plate body 102 positioned within the tissue pocket and a portion of the drainage tube 104 remaining outside the pocket. In Figure 1E, the plate body 102 is inserted into the tissue pocket made by the incision 17, with the entire plate body 102 positioned within the tissue pocket and a portion of the drainage tube 104 remaining outside the pocket. In Figure 1E, the portion of the drainage tube 104 exposed outside the pocket is trimmed, allowing the tube 104 to be inserted 2-3 mm into the anterior chamber (AC). In FIG. 1F, a puncture is made and a sharp needle 19, for example a 23 gauge needle, is inserted into the AC, making a needle track parallel to the iris, with the trimmed end of the drainage tube 104 remaining outside the ocular tissue. In FIG. 1G, the drainage tube 104 is inserted approximately 2-3 mm into the AC through the needle track created in FIG. 1F. In FIG. 1H, the exposed portion of the drainage tube 104 remaining outside the ocular tissue is then covered with a patch graft or covering 106. The patch graft or covering 106 can be a piece of preserved sclera, donor sclera, pericardium, cornea or other suitable patch graft material. The patch graft or covering 106 is then sutured in place and the conjunctiva 13 is closed.

[0008] In the conventional device 100, the plate body 102 has a rigid structure so that a user can hold any part of the plate body 102 using a tool such as medical tweezers, hemostat, or other suitable medical implement for holding the plate body 102, and while holding the plate body 102 with the medical implement, the user can push the plate body 102 into the tissue pocket created by the incision 17, as shown in FIG. 1D. In this way, the conventional device 100 utilizes the rigidity of the plate body 102 for the implantation procedure, and the implantation procedure method as described in FIG. 1D is not suitable for thin materials that are very flexible and collapsible (e.g., foldable, deformable, bendable, or wrinkleable, i.e., wrinkleable), because the pushing action may cause the device to be improperly positioned or components to be improperly positioned, making it difficult, if not impossible, for the user to insert the device using the pushing method. Similarly, prior art devices 100 rely on slippery or low friction surfaces on the device to facilitate the pushing insertion method; therefore, a device with high surface friction will encounter resistance to the pushing action and will be more likely to become distorted during the implant procedure due to the high friction causing the device to collapse (e.g., bend, fold, buckle, deform, or wrinkle).

[0009] Additionally, it is desirable for the device to be of sufficiently thin construction since thinness allows for a low profile and minimizes adverse tissue effects.Therefore, there is a need for a glaucoma drainage device with a thin, flexible body that can be inserted into ocular tissue while avoiding collapse and displacement of the device in situ, and that overcomes the aforementioned limitations of the prior art. Summary of the Invention

[0010] Abstract Disclosed herein are drainage devices for draining bodily fluids from the eye to tissue surrounding the eye, as well as methods for forming implantable drainage devices at least partially within ocular tissue, and methods for using the drainage devices to treat glaucoma.

[0011] According to one example ("Example 1"), a drainage device is configured to drain bodily fluid from an eye to tissue external to the eye, the drainage device being at least partially implantable within the tissue of the eye, the drainage device including a collapsible body portion defining a reservoir and a conduit having a first end fluidly coupled to the reservoir and a second end insertable into the eye to facilitate drainage of bodily fluid into the conduit. The collapsible body portion includes a deformation of the body portion from a first planar state to a second non-planar state when collapsed. In situ, the second non-planar state is at least one of a folded state, a deformed state, a bent state, or a wrinkled state. During implantation, the collapsible body portion includes at least one temporary stiffening element that maintains the collapsible body portion in the first planar state. In some examples, the collapsible body portion can include one or more of at least one temporary reinforcement element that maintains the collapsible body portion in a first planar state during the implant procedure, or a retention portion defined by the collapsible body portion and sized and positioned to transmit a tensile force to the collapsible body portion to maintain the collapsible body portion in the first planar state during the implant procedure.

[0012] According to one example ("Example 2"), further to Example 1, the collapsible body portion includes a delivery member conduit formed on an exterior surface of the collapsible body portion, and the temporary reinforcement element is at least one flexible wire partially received within the delivery member conduit.

[0013] According to one example ("Example 3"), further to Example 2, the delivery member conduit is disposed along the periphery of the reservoir or the periphery of the body member.

[0014] According to one example ("Example 4"), in addition to Example 3, the delivery member conduit is disposed between a periphery of the reservoir and a periphery of the body member.

[0015] According to one example ("Example 5"), further to examples 3 or 4, the delivery member conduit includes a first opening configured to receive a first temporary reinforcement element and a second opening configured to receive a second temporary reinforcement element.

[0016] According to one example ("Example 6"), further to Example 5, the first temporary reinforcement element and the second temporary reinforcement element are configured to overlap within the delivery member conduit.

[0017] According to another example ("Example 7"), further to Example 1, the temporary reinforcement element is attached to an outer surface of the collapsible body portion, and the temporary reinforcement element comprises an absorbent material capable of adhering to eye tissue in which the drainage device is implanted.

[0018] According to another example ("Example 8"), in addition to Example 1, the reservoir can receive a portion of a temporary reinforcement element via a conduit to facilitate delivery of a drainage device to be implanted into the eye tissue, the temporary reinforcement element being retractable from the reservoir after the drainage device has been implanted.

[0019] According to one example ("Example 9"), in addition to any one of the examples above, the collapsible body portion is made from a microporous material.

[0020] According to one example ("Example 10"), in addition to Example 9, the microporous material is expanded polytetrafluoroethylene (ePTFE).

[0021] According to one example ("Example 11"), in addition to Examples 9 or 10, the microporous material includes a plurality of subsections having different pore sizes.

[0022] According to one example ("Example 12"), further to Example 11, the microporous material facilitates absorbing bodily fluids from the reservoir that are released into the external environment surrounding the collapsible body portion.

[0023] According to one example ("Example 13"), further to Example 12, the microporous material reduces tissue ingrowth from the external environment into the reservoir.

[0024] According to one example ("Example 14"), in addition to any one of the examples above, the first planar state is defined by a curved surface that corresponds to the curvature of the eye.

[0025] According to one example ("Example 15"), in addition to any one of the examples above, the collapsible body portion comprises a material that is sufficiently flexible to deform in response to a directional force applied to the body portion during an implantation procedure of the drainage device.

[0026] According to one example ("Example 16"), in addition to Example 15, the collapsible body portion deforms in response to external frictional forces generated by eye tissue when a directional force is applied to the body portion during an implantation procedure of the drainage device.

[0027] According to one example ("Example 17"), in addition to any one of the examples above, the collapsible body portion has a first length in a non-collapsed state in the absence of an external force, a second length shorter than the first length in a collapsed state when an external force is applied, and a third length longer than the second length and shorter than the first length in a resting state after the external force is removed.

[0028] According to one example ("Example 18"), further to Example 17, the third length is less than or equal to about 90% of the first length.

[0029] According to one example ("Example 19"), in addition to any one of the examples above, the collapsible body portion is formed by at least partially bonding a peripheral edge of a first body layer to a peripheral edge of a second body layer.

[0030] According to one example ("Example 20"), in addition to any one of the examples above, the collapsible body portion includes at least one suture hole configured to receive a suture to facilitate attachment of the drainage device to eye tissue.

[0031] According to one example ("Example 21"), in addition to any one of the examples above, the collapsible body portion further includes at least one marker for marking a position of the conduit along the body portion.

[0032] According to one example ("Example 22"), in addition to any of Examples 2-6 above, the delivery member is a flexible delivery wire comprising a nickel-titanium alloy.

[0033] According to one example ("Example 23"), further to the examples above, the collapsible body portion has a thickness of about 0.5 mm or less around the perimeter of the reservoir when the reservoir is empty.

[0034] According to one example ("Example 24"), a drainage device is configured to drain bodily fluid from an eye to tissue external to the eye, the drainage device being at least partially implantable within the tissue of the eye, the drainage device including a collapsible body portion defining a reservoir and a retention portion, and a conduit having a first end fluidly coupled to the reservoir and a second end insertable into the eye to facilitate drainage of bodily fluid to the conduit. The collapsible body portion includes a deformation of the body portion from a first planar state to a second non-planar state when collapsed. In situ, the second non-planar state is at least one of a folded state, a deformed state, a bent state, or a wrinkled state. The retention portion of the collapsible body portion is sized and positioned to transmit a pulling force to the collapsible body portion to maintain the collapsible body portion in the first planar state during implantation.

[0035] According to one example ("Example 25"), in addition to Example 24, the pulling force is provided by a delivery member engaging the retaining portion.

[0036] According to one example ("Example 26"), in addition to Example 25, the retention portion is a pocket partially formed in the collapsible body portion, and the delivery member has a curved portion at a distal end, the curved portion being partially received in the pocket.

[0037] According to one example ("Example 27"), in addition to any one of Examples 24-26, the first planar state is defined by a curved surface that corresponds to the curvature of the eye.

[0038] According to one example ("Example 28"), in addition to any one of Examples 24-27, the collapsible body portion comprises a material that is sufficiently flexible to deform in response to a directional force applied to the body portion during an implantation procedure of the drainage device.

[0039] According to one example ("Example 29"), further to Example 29, the collapsible body portion deforms in response to external frictional forces generated by eye tissue when a directional force is applied to the body portion during an implantation procedure of the drainage device.

[0040] According to one example ("Example 30"), in addition to any one of Examples 24 to 29, the collapsible body portion has a first length in a non-collapsed state in the absence of an external force, a second length shorter than the first length in a collapsed state when an external force is applied, and a third length longer than the second length and shorter than the first length in a resting state after the external force is removed.

[0041] According to one example ("Example 31"), further to Example 30, the third length is less than or equal to about 90% of the first length.

[0042] According to one example ("Example 32"), in addition to any one of Examples 24-31, the collapsible body portion is formed by at least partially bonding a peripheral portion of a first body layer to a peripheral portion of a second body layer.

[0043] According to one example ("Example 33"), in addition to any one of Examples 24-32, the collapsible body portion includes at least one suture hole configured to receive a suture to facilitate attachment of the drainage device to eye tissue.

[0044] According to one example ("Example 34"), in addition to any one of Examples 24-33, the collapsible body portion further includes at least one marker for marking a position of the conduit along the body portion.

[0045] According to one example ("Example 35"), in addition to any of Examples 25 or 26, the delivery member is a flexible delivery wire comprising a nickel-titanium alloy.

[0046] According to one example ("Example 36"), in addition to any one of Examples 24-35, the collapsible body portion has a thickness of about 0.5 mm or less around the perimeter of the reservoir when the reservoir is empty.

[0047] According to one example ("Example 37"), a method of forming an at least partially implantable drainage device within ocular tissue includes disposing one or more layers of material to form a collapsible body portion defining a reservoir, the reservoir configured to receive and accumulate bodily fluid, and securing a conduit to the reservoir such that a first end of the conduit is fluidly coupled to the reservoir and a second end of the conduit is deliverable into the eye, thereby facilitating drainage of bodily fluid into the conduit.

[0048] According to one example ("Example 38"), further to Example 37, the collapsible body portion includes a material that is sufficiently flexible to deform in response to a directional force applied to the body portion during an implantation procedure of the drainage device.

[0049] According to one example ("Example 39"), in addition to Example 38, the collapsible body portion includes a material that is sufficiently flexible to be deformed by an external frictional force generated by applying a directional force to the body portion during an implantation procedure of the drainage device.

[0050] According to one example ("Example 40"), further to Examples 38 or 39, the collapsible body portion has a recovery force that is less than a minimum force required to at least temporarily overcome a force exerted by an entrance port in ocular tissue to at least partially insert the body portion into ocular tissue.

[0051] According to one example ("Example 41"), in addition to any one of Examples 37 to 40, the collapsible body portion has a first length in a non-collapsed state in the absence of an external force, a second length shorter than the first length in a collapsed state when an external force is applied, and a third length longer than the second length and shorter than the first length in a resting state after the external force is removed.

[0052] According to one example ("Example 42"), further to Example 41, the third length is less than or equal to about 90% of the first length.

[0053] According to one example ("Example 43"), in addition to any one of Examples 37-42, the one or more layers of material include a first body layer and a second body layer. The method further includes at least partially adhering a periphery of the first body layer to a periphery of the second body layer to form the collapsible body portion.

[0054] According to one example ("Example 44"), in addition to any one of Examples 37-43, the method further includes forming at least one suture hole in the collapsible body portion configured to receive a suture to facilitate attachment of the drainage device to eye tissue.

[0055] According to one example ("Example 45"), in addition to any one of Examples 37-44, the method further includes forming at least one marker on the collapsible body portion configured to mark a position of the conduit along the body portion.

[0056] According to one example ("Example 46"), in addition to any one of Examples 37-45, the method includes providing at least one support member to facilitate delivery so that the drainage device can be placed in a planar, non-collapsed state to be implanted into the eye tissue, wherein the at least one support member comprises an absorbent material configured to adhere to the eye tissue into which the drainage device is to be implanted, and attaching the at least one support member to an outer surface of the collapsible body portion.

[0057] According to one example ("Example 47"), in addition to any one of Examples 37-45, the method includes inserting a portion of a delivery member into the reservoir via the conduit to facilitate delivery of a drainage device to be implanted in an eye tissue and disposed in a planar, non-collapsed configuration. The delivery member can be retracted from the reservoir after the drainage device is implanted.

[0058] According to one example ("Example 48"), in addition to Examples 46 or 47, the planar configuration is defined by a curved surface that corresponds to the curvature of the eye.

[0059] According to one example ("Example 49"), in addition to any one of Examples 37-48, the delivery member is a flexible delivery wire comprising a nickel-titanium alloy.

[0060] According to one example ("Example 50"), in addition to any one of Examples 37-49, the collapsible body portion comprises a microporous material.

[0061] According to one example ("Example 51"), further to Example 50, the microporous material includes multiple subsections having different porosities.

[0062] According to one example ("Example 52"), further to examples 50 or 51, the microporous material facilitates absorption of bodily fluids from the reservoir that are released into an external environment surrounding the collapsible body portion.

[0063] According to one example ("Example 53"), further to Example 52, the microporous material reduces tissue ingrowth from the external environment into the reservoir.

[0064] According to one example ("Example 54"), in addition to any one of Examples 37-46, the method further includes forming a delivery member retaining portion on the collapsible body portion disposed exterior to and separate from the reservoir, the delivery member retaining portion configured to at least partially receive a delivery member to facilitate delivery of the drainage device to an eye tissue.

[0065] According to one example ("Example 55"), in addition to Example 54, the delivery member retaining portion is a pocket partially formed in the collapsible body portion, and the delivery member has a curved portion at a distal end that is at least partially receivable by the pocket.

[0066] According to one example ("Example 56"), in addition to Example 54, the delivery member retaining portion is a delivery member conduit formed on an outer surface of the collapsible body portion, and the delivery member is at least one flexible wire partially receivable within the delivery member conduit.

[0067] According to one example ("Example 57"), in addition to Example 56, the method further includes disposing the delivery member conduit along a periphery of the reservoir or a periphery of the body member.

[0068] According to one example ("Example 58"), in addition to Example 57, the method further includes disposing the delivery member conduit between a periphery of the reservoir and a periphery of the body member.

[0069] According to one example ("Example 59"), in addition to Examples 57 or 58, the delivery member conduit includes a first opening configured to receive a first flexible wire and a second opening configured to receive a second flexible wire.

[0070] According to one example ("Example 60"), in addition to Example 59, the method further includes inserting the first flexible wire into the delivery member conduit through the first opening and inserting the second flexible wire into the delivery member conduit through the second opening such that the first flexible wire and the second flexible wire overlap within the delivery member conduit during delivery of the drainage device.

[0071] According to one example ("Example 61"), in addition to any one of Examples 37 to 46, the collapsible body portion is configured to be delivered to eye tissue in a folded configuration using a delivery member and then released from the folded configuration for implantation.

[0072] According to one example ("Example 62"), in addition to any one of Examples 37 to 46, the collapsible body portion is configured to be delivered to eye tissue in a circumscribing configuration using a delivery member and then released from the circumscribing configuration for implantation.

[0073] According to one example ("Example 63"), in addition to any one of Examples 37-62, the collapsible body portion has a thickness of about 0.5 mm or less around the periphery of the reservoir when the reservoir is empty.

[0074] According to one example ("Example 64"), a method of treating glaucoma using a drainage device includes releasably coupling at least a portion of a delivery member to a collapsible body portion of the drainage device, the collapsible body portion defining a reservoir arranged to receive and accumulate bodily fluid via a first end of a conduit fluidly coupled to the reservoir, delivering the coupled drainage device to a tissue pocket of an eye to place the collapsible body portion in a planar configuration and in a non-collapsed state, retracting the delivery member from the drainage device to deploy and implant the drainage device at least partially within tissue of the eye, and inserting a second end of the conduit into the eye to facilitate drainage of bodily fluid into the conduit.

[0075] According to one example ("Example 65"), in addition to Example 64, the planar configuration is defined by a curved surface that corresponds to the curvature of the eye.

[0076] According to one example ("Example 66"), in addition to Examples 64 or 65, the collapsible body portion has a first length in an unfolded state in the absence of an external force, a second length shorter than the first length in a folded state when an external force is applied, and a third length longer than the second length and shorter than the first length in a resting state after the external force is removed.

[0077] According to one example ("Example 67"), further to Example 66, the third length is less than or equal to about 85% of the first length.

[0078] According to one example ("Example 68"), in addition to any one of Examples 64-67, the method further includes attaching the drainage device to eye tissue using at least one suture attached to at least one suture hole in the collapsible body portion of the drainage device.

[0079] According to one example ("Example 69"), in addition to any one of Examples 64-68, releasably coupling at least a portion of the delivery member to the collapsible body portion of the drainage device includes inserting a portion of the delivery member through the conduit and into the reservoir to facilitate delivery of the drainage device to be implanted into eye tissue. After the drainage device is implanted, the delivery member is retracted from the reservoir.

[0080] According to one example ("Example 70"), in addition to any one of Examples 64-69, the delivery member is a flexible delivery wire comprising a nickel-titanium alloy.

[0081] According to one example ("Example 71"), in addition to any one of Examples 64-70, releasably coupling at least a portion of the delivery member to the collapsible body portion of the drainage device includes at least partially inserting the delivery member into a delivery member retaining portion formed on the collapsible body portion, the delivery member retaining portion being disposed outside of and separated from the reservoir.

[0082] According to one example ("Example 72"), further to example 71, the delivery member retaining portion is a pocket at least partially formed in the collapsible body portion, and the delivery member has a curved portion at a distal end that can be at least partially received by the pocket.

[0083] According to one example ("Example 73"), further to Example 71, the delivery member retaining portion is a delivery member conduit formed on an outer surface of the collapsible body portion, and the delivery member is at least one flexible wire that can be at least partially received within the delivery member conduit.

[0084] According to one example ("Example 74"), in addition to Example 73, the delivery member conduit is disposed along a periphery of the reservoir or a periphery of the body member.

[0085] According to one example ("Example 75"), in addition to Example 74, the delivery member conduit is disposed between a periphery of the reservoir and a periphery of the body member.

[0086] According to one example ("Example 76"), in addition to any one of Examples 73-75, at least partially inserting the delivery member into the delivery member holding portion includes inserting the first flexible wire into the delivery member conduit through a first opening of the delivery member conduit and inserting the second flexible wire into the delivery member conduit through a second opening of the delivery member conduit such that the first flexible wire and the second flexible wire overlap within the delivery member conduit during delivery of the drainage device.

[0087] According to one example ("Example 77"), in addition to any one of Examples 64-76, the collapsible body portion has a thickness of about 0.5 mm or less around the periphery of the reservoir when the reservoir is empty.

[0088] According to one example ("Example 78"), a drainage device is configured to drain bodily fluid from an eye to tissue external to the eye, the drainage device being at least partially implantable within an eye tissue, the drainage device including a collapsible body portion defining a reservoir and a conduit having a first end fluidly coupled to the reservoir and a second end insertable into the eye to facilitate drainage of bodily fluid to the conduit. The collapsible body portion includes a body portion that, when collapsed, transforms from a first planar state to a second non-planar state. In situ, the second non-planar state is at least one of a folded state, a deformed state, a bent state, or a wrinkled state.

[0089] The foregoing examples are merely examples and should not be construed as limiting or narrowing the scope of any of the inventive concepts provided by the present disclosure. While multiple examples have been disclosed, still other embodiments will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative examples. Accordingly, the drawings and detailed description should be regarded as illustrative in nature and not restrictive. [Brief description of the drawings]

[0090] BRIEF DESCRIPTION OF THE DRAWINGS The accompanying drawings are included to provide a further understanding of the disclosure, and are incorporated in and constitute a part of this specification, illustrating embodiments and, together with the description, serve to explain the principles of the disclosure.

[0091] [Figure 1A] FIG. 1A is a top view of a conventional glaucoma drainage device.

[0092] [Figure 1B] FIG. 1B is a side view of the conventional glaucoma drainage device of FIG. 1A.

[0093] [Figure 1C] FIG. 1C illustrates a method of implanting the conventional glaucoma drainage device of FIG. 1A. [Figure 1D] FIG. 1D illustrates a method of implanting the conventional glaucoma drainage device of FIG. 1A. [Figure 1E] FIG. 1E illustrates a method of implanting the conventional glaucoma drainage device of FIG. 1A. [Figure 1F] FIG. 1F illustrates a method of implanting the conventional glaucoma drainage device of FIG. 1A. [Figure 1G] FIG. 1G illustrates a method of implanting the conventional glaucoma drainage device of FIG. 1A. [Figure 1H] FIG. 1H illustrates a method of implanting the conventional glaucoma drainage device of FIG. 1A.

[0094] [Figure 2A] FIG. 2A is a cross-sectional side view of an eye having an implanted drainage device consistent with various aspects of the present disclosure.

[0095] [Figure 2B] FIG. 2B is a cross-sectional top view of the drainage device of FIG. 2A according to certain embodiments disclosed herein.

[0096] [Figure 2C] FIG. 2C is a top view of the drainage device of FIG. 2A according to certain embodiments disclosed herein.

[0097] [Figure 2D] FIG. 2D is a side view of the drainage device of FIG. 2A according to certain embodiments disclosed herein.

[0098] [Figure 3A] FIG. 3A is a top view of a drainage device according to certain embodiments disclosed herein.

[0099] [Figure 3B] FIG. 3B is a perspective view of the drainage device of FIG. 3A with a delivery member engaged therewith, according to certain embodiments disclosed herein.

[0100] [Figure 3C] FIG. 3C is a cross-sectional side view of the drainage device of FIG. 3A according to certain embodiments disclosed herein.

[0101] [Figure 4A] FIG. 4A is a top view of a drainage device according to certain embodiments disclosed herein.

[0102] [Figure 4B]FIG. 4B is a top view of the drainage device of FIG. 4A with one or more delivery members extending through its delivery member conduit, according to certain embodiments disclosed herein.

[0103] [Figure 5A] FIG. 5A is a top view of a drainage device according to certain embodiments disclosed herein.

[0104] [Figure 5B] FIG. 5B is a top view of a drainage device according to certain embodiments disclosed herein.

[0105] [Figure 6A] FIG. 6A is a top view of a drainage device according to certain embodiments disclosed herein.

[0106] [Figure 6B] FIG. 6B is a top view of a drainage device according to certain embodiments disclosed herein.

[0107] [Figure 7A] FIG. 7A is a cross-sectional top view of a drainage device with a delivery member according to an embodiment disclosed herein.

[0108] [Figure 7B] FIG. 7B is a cross-sectional top view of a drainage device with an alternative delivery member according to an embodiment disclosed herein.

[0109] [Figure 7C] FIG. 7C is a cross-sectional top view of a drainage device with yet another delivery member according to an embodiment disclosed herein.

[0110] [Figure 8A]8A-8D are images of drainage devices implanted in ocular tissue in different configurations, according to embodiments disclosed herein. [Figure 8B] 8A and 8B are images of drainage devices implanted in ocular tissue in different configurations according to embodiments disclosed herein. [Figure 8C] 8A-8C are images of drainage devices implanted in ocular tissue in different configurations according to embodiments disclosed herein. [Figure 8D] 8A-8D are images of drainage devices implanted in ocular tissue in different configurations according to embodiments disclosed herein.

[0111] [Figure 9] FIG. 9 is a detailed view of the microstructure of the drainage device of FIG. 3C according to an embodiment disclosed herein.

[0112] [Figure 10] FIG. 10 is a flow chart of a manufacturing method consistent with various aspects of the present disclosure.

[0113] [Figure 11] 11A-11B are a flowchart of a method of use consistent with various aspects of the present disclosure.

[0114] [Figure 12] 12A-12C are side views of a drainage device when an external force is applied to collapse the drainage device and after the external force is removed, according to some embodiments disclosed herein.

[0115] [Figure 13] FIG. 13 is a side view of a partially collapsed drainage device according to some embodiments disclosed herein as the drainage device is pushed forward to be inserted into the eye tissue. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0116] Detailed Description Definitions and Terminology The present disclosure should not be construed in a limiting sense, for example, the terms used in this application should be interpreted broadly with respect to the meaning that one of ordinary skill in the art would ascribe to such terms.

[0117] With respect to the term imprecision, the terms "about" and "approximately" may be used interchangeably to refer to measurements that include the stated measurements and also measurements that are reasonably close to the stated measurements. Measurements that are reasonably close to the stated measurements deviate from the stated measurements by a reasonably small amount, as understood and readily ascertained by those skilled in the relevant art. Such deviations may result, for example, from measurement errors, differences in calibration of measuring and / or manufacturing equipment, human errors in reading and / or setting measurements, small adjustments made to optimize performance and / or structural parameters to account for differences in measurements associated with other components, specific implementation scenarios, imprecise adjustment and / or manipulation of objects by humans or machines, and / or the like. In cases where it is determined that such reasonably small difference values ​​cannot be readily ascertained by those skilled in the relevant art, the terms "about" and "approximately" may be understood to mean plus or minus 10% of the stated value.

[0118] Description of Various Embodiments Those skilled in the art will readily appreciate that the various aspects of the present disclosure may be implemented by any number of methods and devices configured to perform the intended functions. It should also be noted that the accompanying drawings referenced herein are not necessarily drawn to scale and may be exaggerated to illustrate various aspects of the present disclosure, and in that regard, the drawings should not be construed as limiting.

[0119] As described herein, there is a need for a thin, flexible device with drainage that can be implanted into ocular tissue for the treatment of glaucoma. Such a device can easily conform to the contours of the ocular surface without requiring a preformed curvature in the device's construction, allowing a single device to conform to the contours of any patient's ocular surface, thereby eliminating the need to measure the patient's eye prior to the implantation procedure and then manufacture a device that is custom-fitted to the patient's eye. Other advantages of using a thin, flexible device will be recognized by those skilled in the art based on this disclosure.

[0120] Various features of the devices, systems, and methods disclosed herein can be seen in Figures 2A-2D, 3A-3C, 4A-4B, 5A-5B, 6A-6B, and 7A-7C. Aspects of the disclosure relate to bodily fluid drainage devices, systems, and methods. More specifically, the disclosure relates to devices, systems, and methods for draining aqueous humor from the anterior chamber "AC" of a patient's eye 10 so that the aqueous humor can be reabsorbed elsewhere in the body.

[0121] To that end, Figure 2A is a diagram of an eye 10 having a subconjunctival space 11 between the conjunctiva 13 and the sclera 15 of the eye 10. Implanted within the eye 10 is a drainage system comprising a drainage device 200 in accordance with the principles of the present invention. In one embodiment of the present invention, a mechanism is provided for reabsorbing aqueous humor drained from the anterior chamber "AC" of the eye 10 to reduce or otherwise stabilize intraocular pressure. However, one skilled in the art will appreciate that embodiments of the present invention are also useful in other applications where drainage of fluid for redirection within the body is desired.

[0122] 2B-2D show a drainage device 200 for treating glaucoma according to some embodiments. As shown therein, the glaucoma drainage device 200 has a body portion 202 having a first side 218 and a second side 220 according to some examples. When the drainage device 200 is implanted, the second side 220 is the side that faces the eye and the first side 218 faces away from the eye. In some examples, the body portion 202 has a planar configuration (also referred to as a "first planar state") and is collapsible, i.e. wrinkleable, such that it is foldable, deformable, bendable or wrinkleable (the collapsed configuration is also referred to as a "second non-planar state"). It should be understood that the term "plane" can refer to a plane that follows a different geometry, such as a Euclidean plane or a generally spherical shape. In this case, the plane refers to the two-dimensional surface of a sphere that resembles the eye. Thus, the planar configuration of the drainage device can exhibit a flat shape or a shape having a contour or curvature, for example, that generally matches the contour or curvature of the surface of the eye.

[0123] In some instances, the first side 218 and the second side 220 each include a separately formed layer that is attached or bonded to one another to form the body portion 202. Although described below with reference to the suction conduit 206, it should be understood that the drainage device 200 can be a stand-alone product so long as a portion thereof is configured to receive fluid (e.g., directly from an incision, from the conduit 206, etc.), and therefore should not be considered outside the scope of this disclosure. The drainage device 200 can be fluidly coupled to the suction conduit 206. The suction conduit 206 extends from the anterior chamber "AC" of the eye 10 to the drainage device 200 when implanted. Aqueous humor in the anterior chamber "AC" then flows through the suction conduit 206 to the drainage device 200.

[0124] In some instances, only the second side 220 can be present on the body portion 202 such that the aspiration conduit 206 is disposed on the face of the second side 220 away from the eye. In some instances, the presence of only the second side 220 is sufficient to maintain a bleb in position beneath the outer surface tissue of the eye 10 (i.e., the conjunctiva 13) formed during a treatment procedure or closure. In some instances, the second side 220 is thin and flexible such that the second side 220 is collapsible (e.g., foldable, deformable, bendable, or wrinkleable) or otherwise has the structural characteristics described herein for the body portion 202.

[0125] The material selection of the drainage device 200 can contribute to its functionality and its relatively low profile compared to other devices known in the art. The drainage device 200 can include biocompatible materials, including microporous materials such as expanded polytetrafluoroethylene (ePTFE), as described below. The aspiration conduit 206 is flexible and can include biocompatible materials suitable for use in the construction of elongated members. Such suitable materials can include silicone, polytetrafluoroethylene, polypropylene, polymethylmethacrylate, acrylic, polyurethane, silastic, and metal. Such a configuration of the drainage device 200 is particularly useful for surgical implant procedures. In some instances, the drainage device 200 has a maximum thickness "t2" of less than about 1 mm, less than about 0.8 mm, less than about 0.5 mm, less than about 0.3 mm, less than about 0.1 mm (100 microns), less than about 80 microns, less than about 50 microns, less than about 30 microns, less than about 10 microns, or any suitable value or range therebetween. The maximum thickness is measured when the reservoir is empty and unexpanded.

[0126] Generally, surgical implantation of a drainage device such as the drainage device 200 carries the risk of abnormal pressure within the eye 10. For example, when a drainage device is surgically implanted, such as in a procedure that requires the creation of a bleb under the outer surface tissue (i.e., the conjunctiva 13) of the eye 10, the surrounding tissue emerging from the surgical injury does not provide an appreciable flow resistance to the flow of aqueous humor until sufficient wound healing has occurred. During this early postoperative period, the patient is at risk of hypotony (e.g., too low an intraocular pressure) of the eye 10. To avoid hypotony, measures are taken to manage the flow through the drainage device 200 for a period of time. For example, surgeons conventionally "tie" a portion of the aspiration conduit 206 near its proximal end for a period of time and release the tie after sufficient healing of the surgical wound has occurred and the surrounding tissue provides the necessary flow resistance. In certain commercially available glaucoma shunt devices, a restrictive flow "valve" is added distal to the aspiration conduit 206 where the plate portion is located. However, these devices are relatively stiff and bulky and can still cause hypotony. Advantageously, in contrast, drainage devices, systems and methods according to the principles of the present disclosure include low profile devices that create flow resistance that is appreciable early after surgery to avoid hypotony.

[0127] In this example, the drainage device 200 is positioned in the subconjunctival space 11 between the conjunctiva 13 and the sclera 15 of the eye 10. The drainage system 200 may be oriented such that the first layer 218 extends along the sclera 15 and the second layer 220 extends along the conjunctiva 13. It is understood that the portion of the second layer 220 that interfaces with the conjunctiva 13 may be configured to promote or allow tissue ingrowth, as described below. It is also understood that the portion of the first layer 218 that interfaces with the sclera 15 may additionally or alternatively be configured to promote or allow tissue ingrowth, as described below. Such a configuration helps to minimize relative movement between the drainage device 200 and the surrounding tissue.

[0128] In configurations where the drainage device has only a single layer (i.e., no first side 218, only second side 220), the device can be positioned such that a first surface of the single layer faces the eye and a second surface of the single layer is positioned away from the eye. In some instances, the reservoir of the drainage device remains open and fluid entering the aspiration conduit 206 can flow out into the environment surrounding the drainage device rather than being trapped within the drainage device.

[0129] Additionally, an aspiration conduit 206 extends from the drainage device 200 and through a scleral access, perforation, or hole "H" (e.g., made by a physician during an implantation procedure by known methods) and is shown with a first end 208 (e.g., distal end) fluidly coupled to a reservoir 204 within (at least partially defined by) the body portion 202 and a second end 210 (e.g., proximal end) accessing the anterior chamber "AC" and communicating the port with the anterior chamber. In some embodiments, upon implantation, aqueous humor enters the second end 210 of the aspiration conduit 206 and travels to the first end 208 of the aspiration conduit 206, which is in fluid communication with the drainage device 200. The body portion 202 and the aspiration conduit 206 together can define a flow path through which drainage flows through the drainage device 200. In some embodiments, the first end 208 is positioned within the drainage device 200 such that the drained aqueous humor enters a reservoir 204 defined within the drainage device 200 and penetrates various diffusion membranes of the drainage device 200, where it can be absorbed by surrounding tissue and / or ingrowth tissue.

[0130] In some examples, the suction conduit 206 is disposed along a longitudinal axis LL of the drainage device 200, for example, extending through a center of the drainage device 200. In some examples, the body portion 202 of the drainage device 200 includes a flap 214 formed continuously from the same material that constitutes the body portion 202, with the flap 214 and the body portion 202 defining an integral component. The flap 214 defines an opening 212 through which the conduit 206 can be inserted, and the portion of the flap 214 surrounding the conduit 206 can be bonded to prevent fluid in the reservoir 204 from leaking out of the opening 212. In some examples, as shown in FIG. 2D as viewed along the longitudinal axis LL, the opening 212 surrounding the conduit 206 can be left partially open to allow excess fluid in the reservoir 204 to properly escape. The flap 214 can function as a patch graft or covering component covering the exposed portion of the conduit 206 that remains outside the ocular tissue, and then after the drainage device 200 is implanted, the flap 214 can be sutured in place and the conjunctiva 13 closed. The body portion 202 has a first length "L1", also referred to as the overall length when laid out on a flat surface. The length L1 can be measured from a first end, such as the end of the body portion 202 where the flap 214 begins or the end where the conduit 206 reaches the reservoir 204, to an opposite second end, such as the top of the body portion 202 that is furthest from the first end. Measurements can be made along the longitudinal axis or parallel to the longitudinal axis. Also shown is a transverse axis TT that is transverse to the longitudinal axis LL. By definition, the transverse axis is not parallel to the longitudinal axis. The transverse axis can intersect the longitudinal axis at any suitable angle, such as an acute angle, a perpendicular angle, or an obtuse angle.

[0131] In some examples, adhesive 216 is applied to the first layer 218 or the second layer 220 between the periphery 222 of the body portion 202 and the periphery 224 of the reservoir 204. The first layer 218 and the second layer 220 are adhered to one another to form the body portion 202.

[0132] 3A-3C show another example of a drainage device 300 according to some embodiments disclosed herein. The drainage device 300 includes a body portion 202 and a conduit 206, the body portion 202 further including a delivery member retaining portion 302 formed in the body portion between the periphery 222 and the periphery 224. The retaining portion 302 is any suitable feature that retains at least a portion of a delivery member to facilitate delivery of the drainage device 300 to a target location in the body, such as a treatment side of an eye. The retaining portion 302 can be, for example, a cavity, compartment, pocket, pouch, receptacle, or sac formed in the body portion 202 for at least partially receiving at least a portion of any suitable delivery member, such as the delivery member 304 shown in FIG. 3B. Specifically, the delivery member 304 may resemble a spoon-like shape, i.e., the delivery member 304 may have a straight portion and a curved portion 306 at or near the distal end that is at least partially inserted into the retaining portion 302, such that when the delivery member 304 is pushed in one direction, the drainage device 300 advances in the same direction but follows the delivery member 304 with a pulling motion (due to the pulling force), facilitating delivery of the drainage device 300 to the target location without the drainage device experiencing excessive device collapse, e.g., excessive bending, folding, deformation, bending or wrinkling of the body portion. Thus, the retaining portion 302 may be appropriately sized and positioned to transfer a pulling force to the body portion 202 to maintain the body portion in a planar state during the implantation procedure. The pulling force may be provided by the delivery member 304 when engaged with the retaining portion. In some examples, the delivery member 304 can be a Descemet's membrane endothelial keratoplasty (DMEK) spoon, a double-ended orbital retraction elevator sold by Rumex®, or any other appropriately sized surgical spatula known in the art.

[0133] 3C illustrates how the retention portion 302 is disposed separately from the reservoir 204 and is not fluidly connected to the inner surface 308 of the body portion 202, but rather may be an extension of the outer surface 310 of the body portion 202. The inner surface 308 and the outer surface 310 may refer to the surfaces of either the first body layer 218 or the second body layer 220 that form the body portion 202. In some examples, there may be more than one such retention portion, such as multiple retention portions, each capable of receiving at least a portion of any suitable delivery member. In some examples, different retention portions may be configured to be capable of receiving different types of delivery members.

[0134] 4A and 4B show another example of a drainage device 400 according to some embodiments disclosed herein. The drainage device 400 includes a delivery member conduit 402 disposed on the exterior or outer surface 310 of the body portion 202 of the drainage device 400. The conduit 402 can be formed from any suitable material and have any suitable shape, such as a tubular or other hollow structure, so long as the conduit is configured to allow for releasable engagement with a reinforcing element or support member used during an implant procedure. The conduit 402 can be formed separately from the body portion 202 and then attached or bonded to the outer surface of the body portion 202 when forming the drainage device 400. The conduit 402 can be disposed between the peripheries 222 and 224. The conduit 402 has two openings, a first opening 404 and a second opening 406, that define opposite ends of the conduit 402. In some instances, the opening may be located in an intermediate portion of the conduit 402 between the ends. In some instances, there may be more than two openings in the conduit 402, such as when the conduit is formed from a series of "belt loops" or when the conduit is formed from multiple, shorter lengths of separately formed conduit aligned along the periphery of the body portion 202 rather than a single continuous conduit.

[0135] In one embodiment, one or more support members 408 can be temporarily inserted into the conduit 402 through the first opening 404 and / or the second opening 406 to provide structural stability during delivery of the drainage device 400, i.e., to prevent the drainage device 400 from creasing, folding, or bending during delivery. The support members 408 can be made using any suitable material that provides sufficient rigidity to maintain the structure of the drainage device 400 during delivery, while also allowing sufficient flexibility to allow the support members 408 to be inserted into the delivery member conduit 402 and conform to its internal structure (and curvature, etc.) without breaching the walls of the conduit 402 or deforming the conduit 402 and / or the drainage device 400. In some examples, the support members 408 can be one or more wires. In another example, the conduit 402 can provide a passage for a reinforcing element (support member) that temporarily increases the stiffness of the device 400, such as a coiled wire that is axially twisted into a stiff configuration and untwisted into a relaxed configuration. In another example, the conduit 402 can be pressurized to increase the stiffness of the device 400 along the length of the pressurized conduit 402. Once the device 400 is in the target position, the pressure can be released, reducing or eliminating the stiffness of the device 400 and allowing the device 400 to become fully relaxed.

[0136] FIG. 4B illustrates an example where two wires 408 are inserted into the conduit 402 to support the drainage device 400 during delivery. Each wire 408 has axial strength or stiffness that allows the wires to be pushed or advanced distally without significant bending to advance the supported drainage device 400. For example, a first wire 408A can be inserted into the first opening 404 and a second wire 408B can be inserted into the second opening 406. Within the conduit 402, a portion of each wire can overlap a portion of the other wire. For example, the distal end of the first wire 408A extends to point "A" and the distal end of the second wire 408B extends to point "B", with an overlap of the two wires between points "A" and "B". The overlap may be beneficial to provide added support to the distal portion of the drainage device 400 (i.e., the proximal portion of the overlapped portion of the wires between points "A" and "B") when the user pushes the drainage device 400 forward (distally) during delivery and implantation of the body portion of the drainage device into tissue. Once delivered, the wires 408A and 408B can be pulled or retracted (proximally) to release the drainage device 400 therefrom. The support members, reinforcing elements, or wires as described herein may also be referred to as "temporary reinforcing elements" that reinforce or maintain the collapsible body portion in a planar state. In some examples, the body portion 202 can optionally include both a retaining portion 302 (which can be, for example, a cavity, compartment, pocket, pouch, receptacle or sack) of FIGS. 3A-C and a delivery member conduit 402 for receiving a wire 408 of FIGS. 4A-B to facilitate delivery of the drainage device using one or more delivery means or methods as described above.

[0137] 5A illustrates an example of a drainage device 200 with one or more holes 500 formed in the body portion 202 between the peripheries 222 and 224. The holes 500 are located proximal to the openings 212 in the body portion 202, and can be used as a visual indicator of the position and location of the openings 212 in the body portion 202 when the drainage device 200 is implanted. In some instances, one or more sutures can be passed through the holes 500 to secure the implanted drainage device 200 at a target location. The location of the holes 500 is preferably located at the proximal end of the body portion 202 near the openings 212, such that in some instances, the device can be secured to tissue with sutures at the proximal end of the body portion 202 while the distal end of the body portion 202 remains free to move relative to the securement before, during, and / or after the expansion and contraction of the reservoirs 204 of the body portion 202.

[0138] 5B illustrates an example of a drainage device 200 in which, instead of holes 500, one or more markers 502 are used to identify the location of the openings 212. In some examples, the markers 502 can be radiopaque markers or colored markings disposed on the outer surface 310 of the drainage device 200 or between the layers 218 and 220 that form the body portion 202 of the drainage device 200.

[0139] 6A and 6B show an example of a drainage device 200 with an adhesive support member 600 disposed on the exterior surface 310 of the body portion 202 to provide structural support to the drainage device 200 during delivery. For example, there can be a single support member (as in FIG. 6A) or multiple support members (as in FIG. 6B) having a suitable shape or configuration to reduce wrinkling or collapsing, e.g., folding, deforming, bending, or wrinkling, of the drainage device 200 during delivery. The support members can have any suitable configuration, such as a cross-shaped configuration in FIG. 6A, or linear members radiating from the center of the body portion 202 toward the periphery 222 of the body portion 202, as shown in FIG. 6B. In some examples, the adhesive support member 600 can partially or completely adhere to the surrounding environment after a period of time. Thus, the adhesive support member as described herein can also be referred to as a "temporary reinforcement element." In some embodiments, the absorbent support member 600 can be disposed within the reservoir 204 defined by the body portion 202 and can provide support to the drainage device 200 during the implant procedure. As can be appreciated, bodily fluids that enter the reservoir after the implant procedure can dissolve the support member 600.

[0140] 7A-7C show examples of drainage device 200 in which a support member is provided inside reservoir 204 during delivery. For example, in FIG. 7A, support member 700 (which can be a suitably flexible wire) can extend into reservoir 204 of drainage device 200 and form a curved portion 702 (resembling a question mark) that contacts periphery 224 of reservoir 204 within drainage device 200, allowing a user to then deliver drainage device 200 to a target location without drainage device 200 wrinkling or collapsing (e.g., folding, deforming, bending, or creasing) during delivery.

[0141] In FIG. 7B, both ends of the support member 700 are located outside the drainage device 200, but the curved middle portion 702 of the support member 700 curves to conform to the periphery 224 of the reservoir 204 to facilitate supporting the drainage device 200 during delivery. In FIG. 7C, the support member 700 forms multiple curved middle portions 702A, 702B, and 702C as shown, with a portion of each curved portion configured to contact the periphery 224 of the reservoir 204 to prevent the drainage device 200 from wrinkling or collapsing (e.g., bending, deforming, bending, or wrinkling) during delivery. In the above example, the support member 700 can be moved in and out of the reservoir 204 via the suction conduit 206, which allows the support member to be withdrawn from the drainage device 200 after delivery, for example, by pulling on one end of the support member, or in some cases, both ends of the support member. Thus, the support member as described herein may also be referred to as a "temporary stiffening element." As can be seen from the embodiment shown in Figures 7A-7C, the support member 700 may extend only in a plane aligned with the cross-sectional view of the drainage device 200. Alternatively, the support member 700 may extend in multiple directions toward and away from the eye to provide non-axial support to the device as it is axially inserted into place. Alternatively, the support member 700 may extend along a curved surface defined by the curvature of the eye, such as defined by the spherical shape of the eye.

[0142] 8A-8D show different methods of implanting an exemplary embodiment of the drainage device 200 as described in other embodiments as disclosed herein. In FIG. 8A, the drainage device 200 is laid flat and inserted into a cut or incision 17 in the eye tissue by holding the proximal end (or anterior edge near the suction conduit 206) using any suitable tool, such as toothless forceps, and advancing the drainage device 200 into the subconjunctival space created by the incision 17 while holding the pocket open. A support member as disclosed herein can be implemented to prevent the device 200 from folding or bending on itself.

[0143] In FIG. 8B, forceps are used to hold the drainage device 200 and grip it so that the distal end (or trailing edge) of the device 200 is substantially parallel to the conduit 206. This method facilitates delivery of the device 200 to the desired depth with little or no unwanted longitudinal folding or bending, i.e., folding or bending along the longitudinal axis defined by the forceps (e.g., along the axial length LL shown in FIG. 2B). In some instances, the drainage device 200 may fold or bend along the transverse axis TT (also shown in FIG. 2B) during the procedure, but such folding or bending is less detrimental than longitudinal folding or bending and can be corrected, for example, by using forceps or other tools to "smooth out" such folding or bending after delivery.

[0144] 8C, the drainage device 200 is folded or bent axially (i.e., the folding or bending occurs along the longitudinal axis LL or a line parallel to the axis) and the forceps are used to grasp the distal end or rear edge of the drainage device 200 such that the forceps are substantially parallel to the conduit 206. The device 200 is forced into the subconjunctival space within the pocket formed by the incision 17. This method also facilitates delivery of the device 200 to the desired depth with little or no undesirable axial folding or bending.

[0145] 8D, the drainage device 200 is grasped at one side edge so that the forceps are approximately parallel to the duct 206. The device 200 is then rolled or wrapped around the body of the forceps and then pushed into the subconjunctival space. After inserting the device 200, it is unrolled or unwrapped in situ within the subconjunctival space. This method also facilitates delivery of the device 200 to the desired depth with sufficient axial stiffness and little undesirable axial folding or bending.

[0146] The body portion 202, or the layers 218 and 220 that form the body portion 202, may be fabricated using a microporous material. As one skilled in the art can appreciate with reference to FIG. 9, the microporous aspects and parameters of a microporous material may be defined in a variety of ways. When a microporous material is applied to an ocular drainage device configured for in situ placement within an ocular tissue to facilitate drainage of ocular fluids and maintain healthy intraocular pressure, the microporous properties of such a microporous material may generally be characterized by a volumetric porosity value that is defined by the microporous material and may be defined as the ratio of the volume of air or fluid contained within the microporous material to the overall volume (or total volume) of the microporous material.

[0147] In another definition, volumetric porosity can be defined as the percentage of the volume of a microporous material that is occupied by nonstructural or transitory elements, such as air or other fluids. For example, if the total volume is 100 mm 3 And of those, 30mm 3 For microporous materials that consist of chambers that hold air or fluid, 30% of the volume of the microporous material is empty or temporary space filled with air or other fluid, resulting in a volumetric porosity value of 0.3.

[0148] As can be appreciated, two microporous materials can have the same volumetric porosity but different pore sizes presented to the inflow or outflow of air or fluid. For example, a first material can have a small number of large pores distributed over a certain total volume and a second material can have a larger number of relatively small pores distributed over the same fixed volume, and if the air / fluid volumes of the two materials are the same, then both microporous materials can have the same volumetric porosity.

[0149] As can be further appreciated, the properties of microporous materials used in ocular drainage devices can be defined by the size of the passageways through the microporous material, as well as the pore size measured where the passageways terminate at a surface of the microporous material, or as the pore size measured along the length of the passageway within the material. Microporous materials with small pores or passageways can impede flow through the material, while relatively large pores or passageways can increase the passage of air or fluid into, out of, or within the microporous material.

[0150] As can be further appreciated, the properties of the microporous material can also be defined by the tortuosity of the passages into and through the material, with relatively small or large passages obstructing the fluid path, either by the frequency of tortuosity in the passages or by the placement of obstacles in the fluid path. The air / fluid passage rate through the microporous material can be managed by controlling or defining any of the above properties of the material to provide a material suitable for use in ocular drainage applications.

[0151] For simplicity, the aforementioned characteristics and variables of the microporous materials used in the various embodiments and examples described herein may be expressed simply as volumetric porosity, pore or passage size, or porosity, which may be based on a tortuosity metric. Referring again to Figure 9, the interior of the microporous material may have a variety of porosities (or volumetric porosity, pore size, or tortuosity), as shown in Figure 9. Figure 9 is an enlarged view of the circled portion of the body portion 202 as shown in Figure 3C. The interior portion may extend between an inner surface 308 and an outer surface 310.

[0152] In any of these portions of the body portion 202, the porosity can be in the comparative ranges of small pore size (SP), medium small pore size (MSP), medium pore size (MP), medium large pore size (MLP) and large pore size (LP). For the purposes of this discussion, assuming that the drainage passes through the microporous material along a relatively straight path, sequentially experiencing the porosity of the inner surface 308, the uniform interior portion and the exterior surface 310, the composite flow resistance can be expressed by connecting the respective porosities in a similar manner. For example, the inner surface 308 will typically be of low overall porosity (e.g., to reduce, prevent or inhibit tissue ingrowth into the reservoirs 204), while the interior portion and portions of the exterior surface 310 can have any of the aforementioned porosities. In such a situation, when the interior portion is of medium porosity, e.g., when the interior portion is of medium porosity and the exterior surface 310 is of high porosity, the flow path through the microporous material from the reservoirs 204 to the tissue surrounding the device can be expressed as SP-MP-LP. More examples are described below.

[0153] There can be various flow paths within the microporous material. Relatively straight flow paths can include regions such as SP1-SP4-SP5 or SP3-MLP1-MP1-MSP1. Under certain conditions, for example, when there is high pressure in the reservoir 204, at least some of the flow can proceed through the most direct path through the microporous material, such as SP1-SP4-SP5 or SP2-LP1-LP2. While some flow paths can be relatively straight, there are also non-linear flow paths. For example, under certain conditions, at least some of the flow can flow through regions of progressively less resistance, such as SP1-LP1-LP2 or SP3-MLP1-LP1-LP2. As will be appreciated, the microstructure of the microporous material can undergo a modification process to obtain a particular type of flow through the microstructure. For example, the microstructure can have relatively uniform layers across the layers within the microstructure, or can have variable portions throughout the thickness of the microporous material, as shown here.

[0154] In some examples, the body portion 202 defines a wall thickness extending between the inner surface 308 and the outer surface 310. The wall thickness can define an interior region of the body portion 202 having a transitional porosity between the porosity of the low porosity surface (e.g., having a smaller pore size) of the inner surface 308 and the high porosity surface (e.g., having a larger pore size) of the outer surface 310. Additionally or alternatively, the interior region can have an interior region porosity equal to the porosity of the low porosity surfaces of the inner surface 308 and the outer surface 310. Additionally or alternatively, the interior region can have an interior region porosity equal to the porosity of the low porosity surface of the inner surface 308. Additionally or alternatively, the interior region can have an interior region porosity equal to the porosity of the high porosity surface of the outer surface 310.

[0155] FIG. 10 illustrates a flow chart of a method 1000 consistent with an embodiment of the present disclosure. As shown, the method 1000 includes forming an implantable drainage device at least partially within an ocular tissue. In step 1002, one or more layers of material are disposed to form a collapsible (e.g., foldable, deformable, bendable, or wrinkleable) body portion having a reservoir defined therein. The reservoir can receive and accumulate bodily fluids, such as excess aqueous humor, which can lead to unhealthy pressure buildup. In step 1004, a conduit can be secured to the reservoir, a first end of the conduit can be fluidly coupled to the reservoir, and a second end of the conduit can be inserted into a patient's eye to facilitate drainage of bodily fluids into the conduit.

[0156] In some examples, the method 1000 can include an additional step 1006 in which a support member and / or a retaining portion for the delivery member is provided. The support member and / or the retaining portion can be provided on the collapsible body portion. As disclosed herein, many different types of support members and retaining portions can be implemented. For example, at least one support member is provided, the support member comprising an absorbent material that can be absorbed to the ocular tissue in which the drainage device is implanted. In such cases, the at least one support member can be attached to an outer surface of the body portion.

[0157] In some instances, step 1006 includes inserting a portion of a delivery member through the conduit into the reservoir to facilitate delivery of the drainage device implanted into the ocular tissue. In some instances, the delivery member can be retracted from the reservoir after the drainage device is implanted. The delivery member can be, for example, a flexible delivery wire including, but not limited to, a nickel titanium alloy, or any suitable polymer including, but not limited to, nylon.

[0158] In some examples, step 1006 includes forming a delivery member retention portion on the body portion, the retention portion being capable of being disposed outside or external to the reservoir and separated from the reservoir, the delivery member retention portion being capable of at least partially receiving a delivery member, such as at least a distal portion of the delivery member, to facilitate delivery of the drainage device to the ocular tissue.

[0159] In some instances, the retention portion of the delivery member can be a pocket formed partially in the body portion. The delivery member in such a case can have a curved portion at a distal end that is at least partially receivable by the pocket during delivery.

[0160] In some instances, the retention portion of the delivery member is a conduit, also known as a delivery member conduit, formed on the exterior surface of the body portion to receive the delivery member. The delivery member in such a case can be at least one flexible wire that can be at least partially received within the delivery member conduit during delivery. Step 1006 can further include disposing the delivery member conduit along the periphery of the reservoir or the periphery of the body member and / or disposing the delivery member conduit between the periphery of the reservoir and the periphery of the body member.

[0161] In some examples, the delivery member conduit can have a first opening capable of receiving a first flexible wire and a second opening capable of receiving a second flexible wire, and step 1006 can further include inserting the first flexible wire into the delivery member conduit through the first opening and inserting the second flexible wire into the delivery member conduit through the second opening, such that the first flexible wire and the second flexible wire overlap within the delivery member conduit during delivery of the drainage device.

[0162] FIG. 11A shows a flowchart of a method 1100 consistent with an embodiment of the present disclosure. As shown, the method 1100 includes a step of treating glaucoma using a drainage device. At step 1102, at least a portion of a delivery member is removably coupled to a collapsible (e.g., foldable, deformable, bendable, or wrinkleable) body portion of the drainage device, the body portion defining a reservoir capable of receiving and storing bodily fluid. At step 1104, the delivery member is used to deliver the drainage device to ocular tissue, disposing the collapsible body portion in a planar configuration in an uncollapsed state. In some examples, the planar configuration is defined by a curved surface that corresponds to the curvature of the eye. At step 1106, the delivery member is retracted from the drainage device, deploying the drainage device to be at least partially (or completely) implanted in the ocular tissue. At step 1108, a second end of the conduit is inserted into the eye to facilitate drainage of bodily fluid (such as aqueous humor in the eye) into the conduit. A first end of the conduit is secured to the reservoir and is fluidly coupled with the reservoir.

[0163] In some examples, the method 1100 may further include one or more additional steps including attaching the drainage device to the eye tissue using at least one suture secured in at least one suture hole on a body portion of the drainage device.

[0164] In some instances, step 1102 includes inserting a portion of a delivery member through the conduit into the reservoir to facilitate delivery of the drainage device to be implanted into the ocular tissue. After the drainage device is implanted, the delivery member may be retracted from the reservoir. In such cases, the delivery member may be any suitable flexible delivery wire, including, but not limited to, one formed using a nickel-titanium alloy.

[0165] In some examples, step 1102 includes at least partially inserting the delivery member into a delivery member retaining portion formed on the body portion, the delivery member retaining portion being disposed outside of and separated from the reservoir. The delivery member retaining portion can be a pocket at least partially formed in the body portion, the delivery member having a curved portion at a distal end at least partially receivable by the pocket during delivery.

[0166] In some examples, the retention portion of the delivery member can be a delivery member conduit formed on the exterior surface of the body member. The delivery member can be at least one flexible wire that can be at least partially received within the delivery member conduit. The delivery member conduit can be disposed along a periphery of the reservoir, along a periphery of the body member, and / or between a periphery of the reservoir and a periphery of the body member.

[0167] In some examples, at least partially inserting the delivery member into the retaining portion of the delivery member in accordance with step 1102 can include inserting a first flexible wire into the delivery member conduit through a first opening of the delivery member conduit and inserting a second flexible wire into the delivery member conduit through a second opening of the delivery member conduit such that the first flexible wire and the second flexible wire overlap within the delivery member conduit during delivery of the drainage device.

[0168] 11B shows a flow chart of another method 1110 consistent with an embodiment of the present disclosure. After step 1102 as described above, the coupled drainage device is delivered to the target location in a collapsed state at step 1112. At step 1114, the drainage device is deployed to an uncollapsed state. Deployment may be performed, for example, by at least partially expanding the collapsed drainage device such that the drainage device assumes an uncollapsed state. Alternatively, other suitable methods of uncollapse of the collapsed drainage device may be performed. After the drainage device is uncollapsed, at step 1106, the delivery member is retracted from the drainage device, implanting the drainage device, and at step 1108, inserting one end of the conduit into the eye as described above.

[0169] 12A-12C illustrate the physical properties of an exemplary drainage device, and more specifically its body portion, in response to buckling and recovering at least a portion of its overall length after removal of an external force. In FIG. 12A, the body portion 202 is shown with an external collapsing force 1200 applied to the body portion in a direction indicated by the arrows directed at the body portion. The external collapsing force 1200 can be a directional force 1201, e.g., a frictional force caused by pushing the body portion via a forward force applied by a physician sufficient to push the body portion of the drainage device into the target tissue. As a result, the body portion is folded, bent, deformed, or buckled along the transverse axis TT shown in FIG. 2B, i.e., any axis that intersects with the longitudinal axis LL. The location of the fold (i.e., the axis of the fold) is not necessarily located at or near the center of the body portion, and such folding may occur at any axis along the body portion, including near the periphery 222 of the body portion. During application of the external force 1200, the body portion has a collapsed length "L2" that is shorter or less than the overall length of the body portion, "L1."

[0170] Figure 12B shows the body portion 202 immediately after the external collapsing force 1200 has been removed. Although the shape of the body portion remains the same, the body portion exerts an internal or restoring force 1202 due to the flexible physical properties of the body portion in a direction opposite to the external collapsing force 1200 (i.e., in the direction away from the body portion in the illustrated example). Thus, while in the folded configuration or folded state (also called the non-planar state), the body portion can exert a force to return or revert to its original configuration before the external collapsing force 1200 was applied.

[0171] Figure 12C shows the body portion 202 at a point in time after the external collapsing force 1200 has been removed with no external force applied to the body portion. As shown, the restoring force 1202 has at least partially unfolded the body portion, where the length of the body portion is a length “L3” that is longer than the folded length L2. In some examples, the length L3 is referred to as the rest length of the body portion and is defined as the length of the body portion after the external collapsing force 1200 is applied to fold the body portion and then released such that the restoring force 1202 promotes the unfolding of the folded body portion until no further restoring force is seen.

[0172] Thus, in some examples, when the restoring force 1202 promotes the complete recovery of the body portion and the final state of the body portion is substantially the same as the original state (e.g., as shown in FIG. 2B), L3 is the same as L1 (i.e., L3 = L1).

[0173] Alternatively, in some examples, when the restoring force 1202 partially unfolds the body portion but the body portion cannot return to its original configuration when placed on a flat surface, L3 is greater than L2 (i.e., L3 < L2 < L1). In such cases, L3 can be 50%, 60%, 70%, 75%, 80%, 85%, 90% or any suitable range or value between them relative to L1, and as shown in FIG. 12C, there is still a slight bend in the body portion.

[0174] In some cases, L3 may be defined by the length recovered from L2, which is the shortest length of L1, L2, and L3. That is, if the length of the body portion lost or shortened by folding is defined as (L1-L2), then L3 is mathematically defined as L2+R(L1-L2), where R is the percentage of recovery (any value between 0% and 100%) that the body portion achieves as a result of the recovery force 1202. Thus, if R=0, or no recovery is observed, the result is L3=L2. Alternatively, if R=1, or there is complete recovery, the result is L3=L1. In some instances, when only partial recovery is observed, the value of R can be less than or equal to about 20%, 30%, 40%, 50%, 60%, 70%, 75%, 80%, 85%, 90%, or any suitable value or range therebetween. It should be understood that in order to accurately measure the folding / buckling experienced by the body portion of the drainage device and its recovery therefrom, L1, L2 and L3 are all measured along the same axis (e.g., the longitudinal axis LL as shown).

[0175] 13 shows another example of how the body portion 202 of the drainage device collapses in response to buckling, according to some embodiments. A directional force 1201, e.g., a forward force applied by a physician, is applied to the body portion 202 in a direction substantially parallel to or along the longitudinal axis LL toward a target tissue 1300. The target tissue can be the conjunctiva 13 (as shown in FIGS. 1C-1H) of a patient's eye 10 into which the body portion can be inserted for treatment.

[0176] The target tissue 1300 has an entrance 1302, which in some instances can be an opening formed by a fornix-based incision 17 made in the conjunctiva 13 of the patient's eye 10 using a scalpel as shown in FIG. 1C. The entrance has a height "E" that is smaller (i.e., narrower) than a maximum thickness "t2" of the body portion 202 of the drainage device, and when the body portion attempts to advance through the entrance 1302, the entrance can provide a restraining force 1304 that restrains the body portion from advancing therethrough. The restraining force 1304 can be caused by frictional forces within the target tissue 1300 and the size and shape of the entrance 1302 that requires a certain force to overcome. That is, when a sufficient force is applied in a direction opposite the restraining force 1304 to overcome the restraining force, the entrance 1302 can open further (temporarily or permanently) and receive the body portion 202 of the drainage device. In this manner, the entrance 1302 is adaptable depending on the amount of force applied to it, and the restraining force 1304 is the minimum force that a device needs to exert on the entrance 1302 if the device is dimensionally larger than the size of the entrance, thereby allowing the device to be inserted through the entrance.

[0177] When the body portion 202 exerts an internal force or a restoring force 1202 in a direction opposite to the restraining force 1304 exerted by the inlet 1302, it is observed that the restoring force 1202 of the body portion is smaller than the restraining force 1304 of the inlet. Therefore, if there is not enough force to overcome the restraining force, the body portion 202 is prevented from being inserted forward into the target tissue 1300. Instead, most if not all of the body portion 202 remains outside the target tissue, and when a directional force 1201 is continuously applied, the target tissue 1300 exerts a reaction force 1306 in a direction opposite to the directional force 1201. That is, the reaction force 1306 (which can be the frictional force exerted by the target tissue 1300 in response to the directional force 1201) prevents the longitudinal distal movement of the distal end 1308 of the body portion 202, such that the distal end of the body portion remains outside the target tissue 1300 while the directional force 1201 is being applied. Thus, due to the two opposing forces 1201 and 1306, the body portion 202 collapses in the longitudinal direction (i.e., in a direction with respect to the longitudinal axis L-L) (or, as appropriate, wrinkles, deforms, bends or folds), and when the body portion 202 takes a configuration in which it is collapsed in the longitudinal direction, the longitudinal length of the body portion is shortened from L1 to L2 (where L2 < L1).

[0178] As described herein, any suitable biocompatible material can be used for the body portion and the delivery member conduit. In certain cases, examples of materials can include fluoropolymers such as polytetrafluoroethylene (PTFE) polymers or expanded polytetrafluoroethylene (ePTFE) polymers. In some cases, examples of materials can include, but are not limited to, polyester, silicone, urethane, polyethylene terephthalate or another biocompatible polymer, or combinations thereof. In some cases, bioresorbable or biodegradable materials such as bioresorbable or biodegradable polymers can be used. In some cases, examples of materials can include dacron, polyolefin, carboxymethylcellulose fabric, polyurethane, or other woven, non-woven or film elastomers.

[0179] Additionally, Nitinol (NiTi) may be used as the material of the delivery member described herein, although other materials may be used as the material of the frame, including but not limited to stainless steel, L605 steel, polymers, MP35N steel, polymeric materials, Pyhnox, Elgiloy, or other suitable biocompatible materials, and combinations thereof. The superelastic properties and flexibility of NiTi may improve the conformability of the stent. Additionally, NiTi may be shape-set to a desired shape, i.e., such that when the frame is unconstrained, e.g., when the frame is deployed from a delivery system, the frame tends to self-expand to a desired shape.

[0180] The invention of this application has been described above generally and with reference to specific embodiments. It is apparent to those skilled in the art that various modifications and variations can be made to the embodiments without departing from the scope of the disclosure. Therefore, the embodiments are intended to cover the modifications and variations of the present invention provided they fall within the scope of the appended claims and their equivalents.

Claims

1. 1. A drainage device for draining bodily fluids from an eye to tissue external to the eye, said drainage device being at least partially implantable within eye tissue; a collapsible body portion defining a reservoir; and a conduit having a first end fluidly coupled to the reservoir and a second end insertable into the eye to facilitate drainage of bodily fluid into the conduit; Including, the collapsible body portion includes a body portion that, when collapsed, transforms from a first planar state to a second non-planar state; in situ, the second non-planar state is at least one of a folded state, a deformed state, a bent state, or a wrinkled state; The collapsible body portion comprises: at least one temporary reinforcement element that maintains the collapsible body portion in the first planar state during an implant procedure; or a retention portion defined by the collapsible body portion and sized and positioned to transfer a pulling force to the collapsible body portion to maintain the collapsible body portion in the first planar state during an implantation procedure; A drainage device comprising one or more of the following:

2. A drainage device for draining bodily fluids from an eye to tissue external to the eye, said drainage device being at least partially implantable within tissue of the eye; a collapsible body portion defining a reservoir; and a conduit having a first end fluidly coupled to the reservoir and a second end insertable into the eye to facilitate drainage of bodily fluid into the conduit; Including, the collapsible body portion includes a body portion that, when collapsed, transforms from a first planar state to a second non-planar state; in situ, the second non-planar state is at least one of a folded state, a deformed state, a bent state, or a wrinkled state; During an implant procedure, the collapsible body portion comprises: The drainage device includes at least one temporary reinforcement element that maintains the collapsible body portion in the first planar state.

3. 3. The drainage device of claim 1 or 2, wherein the collapsible body portion includes a delivery member conduit formed on an outer surface of the collapsible body portion, and the temporary reinforcement element is at least one flexible wire partially received within the delivery member conduit.

4. The drainage device of claim 3 , wherein the delivery member conduit is disposed along a periphery of the reservoir or a periphery of the body member.

5. The drainage device of claim 4 , wherein the delivery member conduit is disposed between a periphery of the reservoir and a periphery of the body member.

6. The drainage device of claim 4 or 5, wherein the delivery member conduit includes a first opening configured to receive a first temporary reinforcement element and a second opening configured to receive a second temporary reinforcement element.

7. The drainage device of claim 6 , wherein the first temporary reinforcement element and the second temporary reinforcement element are configured to overlap within the delivery member conduit.

8. 3. The drainage device of claim 1 or 2, wherein the temporary reinforcement element is attached to an outer surface of the collapsible body portion, the temporary reinforcement element comprising an absorbent material capable of adhering to eye tissue in which the drainage device is implanted.

9. 3. The drainage device of claim 1 or 2, wherein the reservoir is capable of receiving a portion of the temporary reinforcement element through the conduit to facilitate delivery of the drainage device to be implanted into eye tissue, and the temporary reinforcement element is retractable from the reservoir after the drainage device has been implanted.

10. The drainage device according to any one of claims 1 to 9, wherein the collapsible body portion is made from a microporous material.

11. The drainage device of claim 10 , wherein the microporous material is expanded polytetrafluoroethylene (ePTFE).

12. The drainage device of claim 10 or 11, wherein the microporous material comprises a plurality of subsections having different pore sizes.

13. The drainage device of claim 12 , wherein the microporous material facilitates absorbing bodily fluids from the reservoir that are released into an external environment surrounding the collapsible body portion.

14. The drainage device of claim 13 , wherein the microporous material reduces tissue ingrowth from the external environment into the reservoir.

15. The drainage device of any one of claims 1 to 14, wherein the first planar state is defined by a curved surface that corresponds to the curvature of the eye.

16. The drainage device of any one of claims 1 to 15, wherein the collapsible body portion comprises a material that is sufficiently flexible to deform in response to a directional force applied to the body portion during an implantation procedure of the drainage device.

17. 17. The drainage device of claim 16, wherein the collapsible body portion deforms in response to external frictional forces generated by eye tissue upon application of a directional force to the body portion during an implantation procedure of the drainage device.

18. The drainage device of any one of claims 1 to 17, wherein the collapsible body portion has a first length in an uncollapsed state in the absence of an external force, a second length shorter than the first length in a collapsed state when an external force is applied, and a third length longer than the second length and shorter than the first length in a resting state after the external force is removed.

19. The drainage device of claim 18 , wherein the third length is less than or equal to about 90% of the first length.

20. The drainage device of any one of claims 1 to 19, wherein the collapsible body portion is formed by at least partially bonding a peripheral edge of a first body layer to a peripheral edge of a second body layer.

21. The drainage device of any one of claims 1 to 20, wherein the collapsible body portion includes at least one suture hole configured to receive a suture to facilitate attachment of the drainage device to eye tissue.

22. The drainage device of any one of claims 1 to 21, wherein the collapsible body portion further comprises at least one marker for marking the position of the conduit along the body portion.

23. The drainage device according to any one of claims 3 to 7, wherein the delivery member is a flexible delivery wire comprising a nickel-titanium alloy.

24. The drainage device of any one of claims 1 to 23, wherein the collapsible body portion has a thickness of about 0.5mm or less around the periphery of the reservoir when the reservoir is empty.

25. 1. A drainage device for draining bodily fluids from an eye to tissue external to the eye, said drainage device being at least partially implantable within eye tissue; a collapsible body portion defining a reservoir and a retention portion; and a conduit having a first end in fluid communication with the reservoir and a second end insertable into the eye to facilitate drainage of bodily fluid into the conduit; Including, the collapsible body portion includes a body portion that, when collapsed, transforms from a first planar state to a second non-planar state; in situ, the second non-planar state is at least one of a folded state, a deformed state, a bent state, or a wrinkled state; A drainage device, wherein the retaining portion of the collapsible body portion is sized and positioned to transmit a pulling force to the collapsible body portion to maintain the collapsible body portion in the first planar state during an implantation procedure.

26. The drainage device of claim 25 , wherein the pulling force is provided by a delivery member engaging the retention portion.

27. The drainage device of claim 26, wherein the retention portion is a pocket partially formed in the collapsible body portion, and the delivery member has a curved portion at a distal end, the curved portion being partially received in the pocket.

28. The drainage device of any one of claims 25 to 27, wherein the first planar state is defined by a curved surface that corresponds to the curvature of the eye.

29. The drainage device of any one of claims 25 to 28, wherein the collapsible body portion comprises a material that is sufficiently flexible to deform in response to a directional force applied to the body portion during an implantation procedure of the drainage device.

30. 30. The drainage device of claim 29, wherein the collapsible body portion deforms in response to external frictional forces generated by eye tissue upon application of a directional force to the body portion during an implantation procedure of the drainage device.

31. The drainage device of any one of claims 25 to 30, wherein the collapsible body portion has a first length in an uncollapsed state in the absence of an external force, a second length shorter than the first length in a collapsed state when an external force is applied, and a third length longer than the second length and shorter than the first length in a resting state after the external force is removed.

32. The drainage device of claim 31 , wherein the third length is less than or equal to about 90% of the first length.

33. The drainage device of any one of claims 25 to 32, wherein the collapsible body portion is formed by at least partially bonding a peripheral edge of a first body layer to a peripheral edge of a second body layer.

34. The drainage device of any one of claims 25 to 33, wherein the collapsible body portion includes at least one suture hole configured to receive a suture to facilitate attachment of the drainage device to eye tissue.

35. The drainage device of any one of claims 25 to 34, wherein the collapsible body portion further comprises at least one marker for marking the location of the conduit along the body portion.

36. 28. The drainage device of claim 26 or 27, wherein the delivery member is a flexible delivery wire comprising a nickel-titanium alloy.

37. The drainage device of any one of claims 25 to 36, wherein the collapsible body portion has a thickness of about 0.5 mm or less around the periphery of the reservoir when the reservoir is empty.

38. 1. A method of forming an implantable drainage device at least partially within an ocular tissue, the method comprising: disposing one or more layers of material to form a collapsible body portion having a reservoir defined therein; and securing the conduit to the reservoir such that a first end of the conduit is fluidly coupled to the reservoir and a second end of the conduit is deliverable into the eye, thereby facilitating drainage of bodily fluid into the conduit; Including, The reservoir is configured to receive and store bodily fluid.

39. 40. The method of claim 38, wherein the collapsible body portion comprises a material that is sufficiently flexible to deform in response to a directional force applied to the body portion during an implantation procedure of the drainage device.

40. 40. The method of claim 39, wherein the collapsible body portion comprises a material that is sufficiently flexible to be deformed by an external frictional force caused by application of a directional force to the body portion during an implantation procedure of the drainage device.

41. 41. The method of claim 39 or 40, wherein the collapsible body portion has a restoring force that is less than a minimum force required to at least temporarily overcome a force exerted by an ocular tissue entry point to at least partially insert the body portion into ocular tissue.

42. 42. The method of any one of claims 38 to 41, wherein the collapsible body portion has a first length in an uncollapsed state in the absence of an external force, a second length shorter than the first length in a collapsed state when an external force is applied, and a third length longer than the second length and shorter than the first length in a resting state after the external force is removed.

43. 43. The method of claim 42, wherein the third length is less than or equal to about 90% of the first length.

44. 44. The method of any one of claims 38-43, wherein the one or more layers of material include a first body layer and a second body layer, the method further comprising at least partially adhering a periphery of the first body layer to a periphery of the second body layer to form the collapsible body portion.

45. 45. The method of any one of claims 38 to 44, further comprising forming at least one suture hole in the collapsible body portion configured to receive a suture to facilitate attachment of the drainage device to eye tissue.

46. The method of any one of claims 38 to 45, further comprising forming at least one marker on the collapsible body portion configured to mark a position of the conduit along the body portion.

47. providing at least one support member that facilitates delivery such that the drainage device implanted in the ocular tissue can be placed in a planar, non-collapsed configuration; and attaching said at least one support member to an exterior surface of said collapsible body portion; Including, The method of any one of claims 38 to 46, wherein the at least one support member comprises an absorbent material configured to adhere to eye tissue into which the drainage device is implanted.

48. The method of any one of claims 38 to 46, comprising inserting a portion of a delivery member into the reservoir via the conduit to facilitate delivery of a drainage device to be implanted in eye tissue so as to be positioned in a planar, non-collapsed state, the delivery member being capable of being retracted from the reservoir after the drainage device has been implanted.

49. 49. The method of claim 47 or 48, wherein the planar configuration is defined by a curved surface that corresponds to the curvature of the eye.

50. The method of any one of claims 38 to 49, wherein the delivery member is a flexible delivery wire comprising a nickel-titanium alloy.

51. The method of any one of claims 38 to 50, wherein the collapsible body portion comprises a microporous material.

52. 52. The method of claim 51, wherein the microporous material comprises a plurality of subsections having different porosities.

53. 53. The method of claim 51 or 52, wherein the microporous material facilitates absorption of bodily fluids from the reservoir that are released into an external environment surrounding the collapsible body portion.

54. 54. The method of claim 53, wherein the microporous material reduces tissue ingrowth from the external environment into the reservoir.

55. 48. The method of any one of claims 38 to 47, further comprising forming a delivery member retaining portion on the collapsible body portion disposed outside the reservoir and separated from the reservoir, the delivery member retaining portion configured to at least partially receive a delivery member to facilitate delivery of the drainage device to eye tissue.

56. 56. The method of claim 55, wherein the delivery member retaining portion is a pocket partially formed in the collapsible body portion, and the delivery member has a curved portion at a distal end that is at least partially receivable by the pocket.

57. 56. The method of claim 55, wherein the delivery member retaining portion is a delivery member conduit formed on an outer surface of the collapsible body portion, and the delivery member is at least one flexible wire partially receivable within the delivery member conduit.

58. 58. The method of claim 57, further comprising disposing the delivery member conduit along a periphery of the reservoir or a periphery of the body member.

59. 60. The method of claim 58, further comprising disposing the delivery member conduit between a periphery of the reservoir and a periphery of the body member.

60. 60. The method of claim 58 or 59, wherein the delivery member conduit includes a first opening configured to receive a first flexible wire and a second opening configured to receive a second flexible wire.

61. 61. The method of claim 60, further comprising inserting the first flexible wire into the delivery member conduit through the first opening and inserting the second flexible wire into the delivery member conduit through the second opening such that the first flexible wire and the second flexible wire overlap within the delivery member conduit during delivery of the drainage device.

62. 48. The method of any one of claims 38 to 47, wherein the collapsible body portion is configured to be delivered to eye tissue in a folded configuration using a delivery member and then released from the folded configuration for implantation.

63. 48. The method of any one of claims 38 to 47, wherein the collapsible body portion is configured to be delivered to eye tissue in a surrounded configuration using a delivery member and then released from the surrounded configuration for implantation.

64. 64. A method according to any one of claims 38 to 63, wherein the collapsible body portion has a thickness of about 0.5mm or less around the periphery of the reservoir when the reservoir is empty.

65. 1. A method of treating glaucoma using a drainage device, the method comprising: releasably coupling at least a portion of a delivery member to a collapsible body portion of the drainage device, the collapsible body portion defining a reservoir disposed to receive and accumulate bodily fluid via a first end of a conduit fluidly coupled to the reservoir; delivering the coupled drainage device to the tissue pocket of the eye to place the collapsible body portion in a planar configuration and uncollapsed; retracting the delivery member from the drainage device to deploy the drainage device to implant at least partially within eye tissue; and inserting a second end of the conduit into the eye to facilitate drainage of bodily fluid into the conduit; A method comprising:

66. 66. The method of claim 65, wherein the planar configuration is defined by a curved surface that corresponds to the curvature of the eye.

67. 67. The method of claim 65 or 66, wherein the collapsible body portion has a first length in an unfolded state in the absence of an external force, a second length shorter than the first length in a folded state when an external force is applied, and a third length longer than the second length and shorter than the first length in a resting state after the external force is removed.

68. 68. The method of claim 67, wherein the third length is less than or equal to about 85% of the first length.

69. 69. The method of any one of claims 65 to 68, further comprising attaching the drainage device to eye tissue using at least one suture attached to at least one suture hole in the collapsible body portion of the drainage device.

70. Removably coupling at least a portion of the delivery member to the collapsible body portion of the drainage device includes: inserting a portion of the delivery member through the conduit and into the reservoir to facilitate delivery of the drainage device implanted into an ocular tissue; The method of any one of claims 65 to 69, wherein the delivery member is retracted from the reservoir after the drainage device is implanted.

71. The method of any one of claims 65 to 70, wherein the delivery member is a flexible delivery wire comprising a nickel-titanium alloy.

72. Removably coupling at least a portion of the delivery member to the collapsible body portion of the drainage device includes: at least partially inserting the delivery member into a delivery member retaining portion formed in the collapsible body portion; 72. The method of any one of claims 65 to 71, wherein the delivery member retaining portion is disposed outside of and separate from the reservoir.

73. 73. The method of claim 72, wherein the delivery member retaining portion is a pocket at least partially formed in the collapsible body portion, and the delivery member has a curved portion at a distal end that can be at least partially received by the pocket.

74. 73. The method of claim 72, wherein the delivery member retaining portion is a delivery member conduit formed on an outer surface of the collapsible body portion, and the delivery member is at least one flexible wire that can be at least partially received within the delivery member conduit.

75. 75. The method of claim 74, wherein the delivery member conduit is disposed along a periphery of the reservoir or a periphery of the body member.

76. 76. The method of claim 75, wherein the delivery member conduit is disposed between a periphery of the reservoir and a periphery of the body member.

77. At least partially inserting the delivery member into the delivery member retaining portion comprises:

77. The method of any one of claims 74 to 76, comprising inserting a first flexible wire into the delivery member conduit through a first opening of the delivery member conduit and inserting the second flexible wire into the delivery member conduit through a second opening of the delivery member conduit such that the first flexible wire and the second flexible wire overlap within the delivery member conduit during delivery of the drainage device.

78. 78. A method according to any one of claims 65 to 77, wherein the collapsible body portion has a thickness of about 0.5mm or less around the periphery of the reservoir when the reservoir is empty.

79. A drainage device configured to drain bodily fluid from an eye to tissue external to the eye, the drainage device being at least partially implantable within the tissue of the eye; a collapsible body portion defining a reservoir; and a conduit having a first end in fluid communication with the reservoir and a second end insertable into the eye to facilitate drainage of bodily fluid into the conduit; Including, the collapsible body portion includes a body portion that, when collapsed, transforms from a first planar state to a second non-planar state; The drainage device, in situ, wherein the second non-planar state is at least one of a folded state, a deformed state, a bent state, or a wrinkled state.

Citation Information

Patent Citations

  • Glaucoma graft with temporary flow-restricting seal

    JP1998503405A

  • Glaucoma treatment system and method

    JP2020509892A

  • Ocular implant with shape change capabilities

    US20100137981A1